Brunn Carsten

CIK 00017602292 companiesFREDERICK, MD

SEC Profile

Transactions

Companies

Filings

CIK

0001760229

Recent Transactions

50 trades

Sale
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2026-01-06$6.82/sh−23,766→ 323,530 total
Award
Cartesian Therapeutics, Inc.$RNAC
Employee Stock Option (right to buy)
2026-01-02+415,700→ 415,700 total
Award
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2026-01-02+143,200→ 347,296 total
Sale
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2025-01-06$16.83/sh−8,708→ 204,096 total
Sale
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2025-01-03$16.72/sh−8,563→ 212,804 total
Award
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2025-01-02+57,500→ 221,367 total
Award
Cartesian Therapeutics, Inc.$RNAC
Employee Stock Option (right to buy)
2025-01-02+169,100→ 169,100 total
Award
Cartesian Therapeutics, Inc.$RNAC
Employee Stock Option (right to buy)
2024-01-02+5,971,000→ 5,971,000 total
Award
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2024-01-02+4,654,100→ 4,916,056 total
Disposition to Issuer
Cartesian Therapeutics, Inc.$RNAC
Employee Stock Option (right to buy)
2023-11-13$0.93/sh−1,275,000→ 0 total
Disposition to Issuer
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2023-11-13$2.06/sh−55,000→ 728,081 total
Disposition to Issuer
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2023-11-13$2.06/sh−13,600→ 714,481 total
Disposition to Issuer
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2023-11-13$2.06/sh−169,725→ 544,756 total
Disposition to Issuer
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2023-11-13$2.06/sh−282,800→ 261,956 total
Disposition to Issuer
Cartesian Therapeutics, Inc.$RNAC
Employee Stock Option (right to buy)
2023-11-13−1,000,000→ 0 total
Disposition to Issuer
Cartesian Therapeutics, Inc.$RNAC
Employee Stock Option (right to buy)
2023-11-13−330,000→ 0 total
Disposition to Issuer
Cartesian Therapeutics, Inc.$RNAC
Employee Stock Option (right to buy)
2023-11-13$0.31/sh−400,000→ 0 total
Disposition to Issuer
Cartesian Therapeutics, Inc.$RNAC
Employee Stock Option (right to buy)
2023-11-13−600,000→ 0 total
Disposition to Issuer
Cartesian Therapeutics, Inc.$RNAC
Employee Stock Option (right to buy)
2023-11-13−75,000→ 0 total
Disposition to Issuer
Cartesian Therapeutics, Inc.$RNAC
Employee Stock Option (right to buy)
2023-11-13−670,000→ 0 total
Disposition to Issuer
Cartesian Therapeutics, Inc.$RNAC
Employee Stock Option (right to buy)
2023-11-13−163,000→ 0 total
Disposition to Issuer
Cartesian Therapeutics, Inc.$RNAC
Employee Stock Option (right to buy)
2023-11-13−1,056,100→ 0 total
Sale
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2023-09-25$1.06/sh−2,932→ 783,081 total
Sale
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2023-01-05$1.11/sh−77→ 786,013 total
Sale
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2023-01-05$1.13/sh−13,396→ 786,090 total
Sale
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2023-01-04$1.13/sh−27,549→ 799,534 total
Sale
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2023-01-04$1.15/sh−48→ 799,486 total
Award
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2023-01-02+282,800→ 827,083 total
Award
Cartesian Therapeutics, Inc.$RNAC
Employee Stock Option (right to buy)
2023-01-02+1,275,000→ 1,275,000 total
Sale
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2022-12-05$1.33/sh−4,522→ 544,283 total
Exercise/Conversion
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2022-12-01+10,938→ 548,805 total
Exercise/Conversion
Cartesian Therapeutics, Inc.$RNAC
Restricted Stock Units
2022-12-01−10,938→ 0 total
Sale
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2022-09-28$1.66/sh−2,692→ 537,867 total
Sale
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2022-09-02$1.85/sh−4,768→ 540,559 total
Exercise/Conversion
Cartesian Therapeutics, Inc.$RNAC
Restricted Stock Units
2022-09-01−10,937→ 10,938 total
Exercise/Conversion
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2022-09-01+10,937→ 545,327 total
Award
Surface Oncology, Inc.
Stock Option (Right to Buy)
2022-06-28+48,000→ 48,000 total
Exercise/Conversion
Cartesian Therapeutics, Inc.$RNAC
Restricted Stock Units
2022-06-01−10,938→ 21,875 total
Exercise/Conversion
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2022-06-01+10,938→ 534,390 total
Sale
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2022-03-02$1.81/sh−5,443→ 523,452 total
Exercise/Conversion
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2022-03-01+10,937→ 528,895 total
Exercise/Conversion
Cartesian Therapeutics, Inc.$RNAC
Restricted Stock Units
2022-03-01−10,937→ 32,813 total
Sale
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2022-01-05$3.09/sh−13,597→ 517,958 total
Award
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2022-01-03+226,300→ 531,555 total
Award
Cartesian Therapeutics, Inc.$RNAC
Employee Stock Option (right to buy)
2022-01-03+1,056,100→ 1,056,100 total
Sale
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2021-12-10$2.99/sh−17,196→ 305,255 total
Award
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2021-12-08+37,500→ 322,451 total
Sale
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2021-12-02$2.96/sh−4,746→ 284,951 total
Exercise/Conversion
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2021-12-01+10,938→ 289,697 total
Exercise/Conversion
Cartesian Therapeutics, Inc.$RNAC
Restricted Stock Units
2021-12-01−10,938→ 43,750 total

Companies

Recent Filings

Address

C/O CARTESIAN THERAPEUTICS, INC. 7495 NEW HORIZON WAY

FREDERICK, MD, 21703

View on SEC.gov